SBMP-microcarrier
Financiado
SBMP - disrupting the manufacturing of biological drugs through a ground-breakin...
SBMP - disrupting the manufacturing of biological drugs through a ground-breaking nanotechnology-based microcarrier
Cellevate proposes a completely novel type of nanofibrous microcarriers for adherent cell culture in bioreactors based on the proprietary Superior Biologics Manufacturing Platform (SBMP). It is a game-changing deep-tech innovation...
Cellevate proposes a completely novel type of nanofibrous microcarriers for adherent cell culture in bioreactors based on the proprietary Superior Biologics Manufacturing Platform (SBMP). It is a game-changing deep-tech innovation for the biopharmaceutical industry. SBPM-microcarriers
are highly customizable, faithfully replicate the 3D extracellular environment found in the human body, and provide a 60 times larger area for cell growth compared to competitive solutions. The unique scaffold properties are a result of a patent-pending nanofiber scaffold production
technology (PCT/EP2020/081958) which creates networks of polymer nanofibers that can be handled in a liquid form, unachievable by competing solutions. By offering high yields and ensuring the optimal conditions for human cell growth, SBMP-microcarriers have the potential to transform the
biopharmaceutical market by pushing the limits of today’s biological drugs production to an unachievable level of quality and efficiency.
ver más
Duración del proyecto: 22 meses
Fecha Inicio: 2022-11-11
Fecha Fin: 2024-09-30
Fecha Fin: 2024-09-30
Línea de financiación: concedida
El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-09-30
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
HORIZON-EIC-2022-ACCELERATOROPEN-01:
EIC Accelerator Open
Cerrada
hace 1 año
Presupuesto
El presupuesto total del proyecto asciende a
4M€
Líder del proyecto
CELLEVATE AB
No se ha especificado una descripción o un objeto social para esta compañía.
